Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-10-28

FDA Approved: AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL — Original Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved Ajanta Pharma USA Inc.'s original ANDA for a generic combination of amlodipine besylate and olmesartan medoxomil for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine Besylate and Olmesartan Medoxomil (amlodipine besylate and olmesartan medoxomil)

Snippet

ORIG AP for AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL (AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL)